Medpace Holdings
Stock Forecast, Prediction & Price Target
Medpace Holdings Financial Estimates
Medpace Holdings Revenue Estimates
Medpace Holdings EBITDA Estimates
Medpace Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.14B N/A | $1.45B 27.80% | $1.88B 29.16% | Avg: $2.52B Low: $2.47B High: $2.56B avg. 33.71% | Avg: $2.90B Low: $2.86B High: $2.93B avg. 15.25% | Avg: $3.34B Low: $3.29B High: $3.38B avg. 15.09% | Avg: $4.14B Low: $4.08B High: $4.19B avg. 24.01% |
Net Income
% change YoY
| $181.84M N/A | $245.36M 34.93% | $282.81M 15.25% | Avg: $421.90M Low: $406.42M High: $428.26M avg. 49.18% | Avg: $493.39M Low: $463.72M High: $535.04M avg. 16.94% | Avg: $567.78M Low: $556.15M High: $575.56M avg. 15.07% | Avg: $700.18M Low: $685.83M High: $709.77M avg. 23.31% |
EBITDA
% change YoY
| $219.73M N/A | $301.03M 37.00% | $363.15M 20.63% | Avg: $488.36M Low: $478.59M High: $496.17M avg. 34.47% | Avg: $562.86M Low: $553.99M High: $568.79M avg. 15.25% | Avg: $647.82M Low: $637.61M High: $654.65M avg. 15.09% | Avg: $803.40M Low: $790.73M High: $811.86M avg. 24.01% |
EPS
% change YoY
| $5.06 N/A | $7.57 49.60% | $9.2 21.53% | Avg: $13.14 Low: $12.76 High: $13.45 avg. 42.84% | Avg: $15.46 Low: $14.56 High: $16.8 avg. 17.63% | Avg: $17.83 Low: $17.47 High: $18.08 avg. 15.35% | Avg: $21.99 Low: $21.54 High: $22.29 avg. 23.31% |
Operating Expenses
% change YoY
| $129.54M N/A | $153.74M 18.68% | $187.68M 22.07% | Avg: $242.38M Low: $237.53M High: $246.26M avg. 29.14% | Avg: $279.36M Low: $274.95M High: $282.30M avg. 15.25% | Avg: $321.53M Low: $316.46M High: $324.91M avg. 15.09% | Avg: $398.74M Low: $392.45M High: $402.94M avg. 24.01% |
FAQ
What is Medpace Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 26.13% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is 406.42M, average is 421.90M and high is 428.26M.
What is Medpace Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 22.01% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $2.47B, average is $2.52B and high is $2.56B.
What is Medpace Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 24.78% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is $12.76, average is $13.14 and high is $13.45.
What is the best performing analyst?
In the last twelve months analysts have been covering Medpace Holdings stock. The most successful analyst is Eric Coldwell.